12:37 IST
NSE
Other Announcement
Indoco Remedies Other Announcement
Indoco Remedies disclosed an unsolicited Crisil ESG rating of 'Crisil ESG 60'. The company notes it did not engage Crisil for the assessment.
Indoco Remedies Ltd
- Share price
- ₹245.90
- Market cap
- ₹2,270 Cr
- Revenue (annual)
- ₹1,845 Cr
- Net profit (annual)
- ₹-95.14 Cr
- P/E (TTM)
- 403.1×Sector 47.4×
- Promoter holding
- 58.86%+0.00% QoQ
- FII holding
- 1.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
17:56 IST
BSE
Merger & Restructuring
Indoco Remedies Merger & Restructuring Worth ₹0.01 Cr
Indoco Remedies will incorporate a new wholly owned subsidiary, Warren Lifesciences Private Limited, for the pharmaceutical business with an initial capital of Rs. 1 Lakh.
- Value
- ₹0.01 Cr
13:04 IST
BSE
Annual General Meeting
Indoco Remedies Annual General Meeting
Indoco Remedies filed proceedings of its 79th AGM held on 17 September 2026. Shareholders voted on nine resolutions including dividend and borrowing limits.
09:35 IST
BSE
Promoter Buying
Indoco Remedies Promoter Buying
Indoco Remedies promoter Aditi M. Panandikar and PAC bought 38,930 shares on the open market, raising aggregate holding to 7.30%. No transaction price is disclosed in the filing.
- Promoter stake change
- +0.04%
19:32 IST
BSE
Promoter Buying
Indoco Remedies Promoter Buying: ₹0.92 Cr
Promoters Aditi M. Panandikar, Madhura Suresh Kare, Suresh G. Kare, and Aruna Suresh Kare acquired Indoco Remedies Ltd shares via market purchases, totaling ₹0.92 Crore.
- Value
- ₹0.92 Cr